Adamed (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Warsaw
Adamed is a Polish pharma company.
Average round investment:9.57M USD
Average number per year:1.0
Distribution:
2025 (1)2022 (1)2021 (1)
Portfolio companies:
One Biosciences
Apeiron Synthesis
Telemedico
One Biosciences
Apeiron Synthesis
Telemedico
Mostly invests in:
Poland (2)
Biotech (2)
Poland (2)
Biotech (2)
3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Adamed
| Name | Criteria | |
|---|---|---|
![]() |
Alfabeat
92%
|
|
![]() |
EIT Digital
89%
|
|
![]() |
Broadview Ventures
89%
|
|
![]() |
Cultivation Capital
89%
|
|
![]() |
Lukasz Gadowski
89%
|
|
![]() |
MA Ventures
89%
|
|
![]() |
Mediaset Group
89%
|
|
![]() |
Prosegur Tech Ventures
89%
|
|
![]() |
Starbright Invest
89%
|
|
![]() |
Thomas Madsen-Mygdal
89%
|
|







Netherlands
Austria
Germany
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Ireland
Portugal
United Kingdom